Brighthouse Financial Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Brighthouse Financial is de winst gegroeid met een gemiddeld jaarlijks percentage van 15.8%, terwijl de Insurance industrie de winst jaarlijks groeide met 14.6%. De inkomsten zijn gegroeid met een gemiddelde van 6.8% per jaar.
Belangrijke informatie
15.78%
Groei van de winst
11.66%
Groei van de winst per aandeel
| Insurance Groei van de industrie | 8.02% |
| Inkomstengroei | 6.85% |
| Rendement op eigen vermogen | -1.07% |
| Nettomarge | -2.74% |
| Laatste winstupdate | 31 Mar 2026 |
Recente prestatie-updates uit het verleden
Recent updates
Narratiefupdate • May 07
BHF: Aquarian Go Private Deal Outcome Will Drive Next Upside Step
Analysts kept their $70.00 price target on Brighthouse Financial steady, making only modest adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E, following recent Street research that re-initiated coverage at a neutral stance. Analyst Commentary Bullish analysts see the reaffirmed US$70 price target as a signal that recent research supports the current valuation framework, even after fine tuning inputs such as discount rate, revenue growth, profit margins and assumed future P/E.
Narratiefupdate • Apr 20
BHF: Market Perform Stance Will Likely Cap Upside Before Take Private
Analysts keep their fair value estimate for Brighthouse Financial steady at $55.00. They cite recent Market Perform research that points to only modest tweaks in discount rate, revenue growth, profit margin, and forward P/E assumptions rather than a material shift in the investment case.Narratiefupdate • Apr 06
BHF: Aquarian Go Private Outcome Will Drive Next Leg Of Upside
Narrative Update: Brighthouse Financial Analysts have adjusted their outlook on Brighthouse Financial, trimming the implied forward P/E in their models and revisiting assumptions on discount rate, revenue growth, and profit margin. Street research, including a downgrade to Equal Weight with an unchanged $65 price target and a Market Perform re-initiation, reflects a view that the Aquarian transaction and the possibility of the company going private are already well reflected in the current valuation and price targets.Seeking Alpha • Apr 05
Brighthouse Financial: A Deal-Driven Opportunity, Not A Long-Term Compounder
Summary Brighthouse Financial is now an event-driven arbitrage play, anchored by Aquarian Capital's $70/share acquisition offer. BHF trades at a deep 0.5x P/B discount, reflecting structural risks, regulatory uncertainty, and skepticism about long-term value outside the pending deal. Record 2025 annuity sales and a 456% RBC ratio highlight operational strength, but high leverage and volatile earnings underscore balance sheet sensitivity. The arbitrage opportunity offers a potential 14% upside but is constrained by regulatory approval risks and weak organic growth prospects. Read the full article on Seeking AlphaNarratiefupdate • Mar 23
BHF: Aquarian Take Private Path Will Likely Keep Risk Return Balanced
Analysts have trimmed their outlook for Brighthouse Financial, with the consensus price target moving from $65 to $55. They see the Aquarian deal as already reflected in the valuation and now expect a more measured risk and return profile following the downgrade to Equal Weight.
Narratiefupdate • Mar 09
BHF: Aquarian Take-Private And Sector Headwinds Will Shape 2026 Outlook
Narrative Update on Brighthouse Financial The analyst price target for Brighthouse Financial has been reaffirmed at $65, as analysts view the Aquarian deal as already reflected in the valuation and expect the transaction to proceed with Brighthouse ultimately being taken private. Analyst Commentary Recent commentary on Brighthouse Financial centers on how fully the Aquarian transaction is reflected in the current share price, as well as broader themes like capital strength, cash generation, and sector consolidation.Narratiefupdate • Mar 09
BHF: Aquarian Take Private Scenario Will Anchor Upside Case
Analysts have trimmed their fair value estimate for Brighthouse Financial from $72.00 to $70.00, citing updated assumptions on growth, margins, and discount rates, as well as a more neutral stance following recent views that the pending Aquarian transaction and a potential take private outcome are already reflected in the stock. Analyst Commentary Recent commentary has shifted to a more balanced stance on Brighthouse Financial, with some prior optimism now tempered by the view that key corporate events are already captured in the current share price.Narratiefupdate • Feb 22
BHF: Aquarian Take-Private Scenario Will Likely Cap Future Upside Potential
Narrative Update Analysts have kept their $65 price target for Brighthouse Financial unchanged, citing that the expected Aquarian transaction and updated assumptions around higher projected revenue growth, improved profit margins, and a lower future P/E are already reflected in the valuation. Analyst Commentary Bearish analysts are taking a more cautious stance on Brighthouse Financial, even with the Aquarian transaction and a US$65 price target already on the table.Narratiefupdate • Feb 08
BHF: Aquarian Takeout And Sector Headwinds Will Shape 2026 Risk Reward
Analysts held their fair value estimate for Brighthouse Financial steady at $65.50, noting that recent price target actions and downgrades reflect a view that the announced Aquarian takeout at $70 per share and the expected completion of that transaction are already well reflected in the stock. Analyst Commentary Recent research suggests that most of the value from the proposed Aquarian acquisition is already reflected in Brighthouse Financial's share price, with analysts focusing less on near term upside and more on deal completion and relative opportunity versus other names.Narratiefupdate • Jan 25
BHF: Take Private Spread And Sector Headwinds Will Shape 2026 Returns
Analysts have nudged their 12 month price target for Brighthouse Financial slightly higher to about US$65.50. This reflects a balanced view that incorporates the Aquarian take private deal, more neutral ratings, and only modest tweaks to long term growth, margin, and P/E assumptions.Narratiefupdate • Jan 11
BHF: Aquarian Take Private Terms And Sector Headwinds Will Shape Returns
Narrative Update Opening Analysts have kept their price target for Brighthouse Financial steady at $65.50, with the unchanged valuation reflecting expectations that the Aquarian take private deal and recent rating shifts to more neutral stances already capture the key risks and potential rewards in the shares. Analyst Commentary Recent research updates around Brighthouse Financial cluster around the Aquarian acquisition at $70 per share, with several firms resetting ratings closer to neutral as they see the deal terms and current trading levels already reflecting much of the expected outcome.Narratiefupdate • Dec 24
BHF: Deal-Dependent Upside Will Likely Offer Limited Future Return Potential
Analysts have raised their fair value estimate for Brighthouse Financial to $55 from $42 as they factor in the proposed $70 per share takeout, a lower perceived risk profile reflected in a reduced discount rate, and somewhat more modest long term growth and profitability assumptions alongside higher expected exit multiples. Analyst Commentary Recent Street research reflects a more balanced, and in some cases cautious, stance on Brighthouse Financial following the announced acquisition, with several bearish analysts highlighting limited upside to the agreed takeout valuation and execution risk around the closing of the deal.Narratiefupdate • Dec 10
BHF: Aquarian Buyout Price And Deal Execution Will Shape Future Return Profile
Analysts have trimmed their price target on Brighthouse Financial by about $1 to roughly $66 per share, reflecting the stock's limited upside following the agreed $70 per share acquisition by Aquarian and the view that other names now offer more attractive intermediate term return potential, despite supportive earnings and claims trends. Analyst Commentary Street research following the Aquarian buyout announcement reflects a more balanced stance on Brighthouse Financial, with most commentary emphasizing limited upside to the agreed transaction price and the shift in focus toward execution through closing rather than long term standalone growth.Narratiefupdate • Nov 26
BHF: Takeover Agreement And Acquisition Uncertainties Will Define Returns Ahead
Brighthouse Financial’s analyst price target has been raised from approximately $60.89 to $66.14 per share. Analysts cite expectations for stronger revenue growth and lower discount rates, following recent takeover activity and market reassessment.Narratiefupdate • Nov 07
BHF: Acquisition Agreement And Earnings Tailwinds Will Shape Risk And Opportunity
Analysts have raised their fair value estimate for Brighthouse Financial from $56.22 to $60.89 per share. This change reflects improved acquisition prospects and anticipated earnings tailwinds.Narratiefupdate • Aug 15
Aging Population And Digital Transformation Will Expand Market Opportunities
Analysts have reduced EPS estimates for Brighthouse Financial amid sector-wide headwinds and declining variable investment income, but ongoing buyout interest and potential acquisition premiums provide support, resulting in an unchanged consensus price target of $56.22. Analyst Commentary Bearish analysts cite continued fee and spread headwinds and have reduced EPS estimates for Brighthouse Financial and the broader life insurance sector.Nieuw narratief • May 26
US Aging Demographics Will Boost Annuity Demand
Strong demand for retirement solutions and product innovation are driving revenue growth, sales volume, and market competitiveness for Brighthouse.Seeking Alpha • Mar 01
Brighthouse Financial: Capital Challenges Limit Upside (Rating Downgrade)
Summary Shares of Brighthouse Financial surged on M&A rumors but pulled back due to mixed results and unclear strategic direction; I recommend selling shares. Private equity interest in BHF is uncertain due to its complex annuity portfolio and capital constraints, and the best case is likely a minority stake sale. BHF's capital generation issues and statutory earnings power are concerning, with limited prospects for meaningful dividends to the holding company until 2027. Despite solid non-GAAP earnings, the company's underwhelming capital generation and complex financial maneuvers make shares unattractive; I prefer stocks with higher capital return yields like Jackson. Read the full article on Seeking AlphaSeeking Alpha • Nov 14
Brighthouse Financial: Capital Generation Remains Concerning
Summary Brighthouse Financial has had a disappointing performance, gaining 12% but underperforming the market, with volatile shares due to mixed quarterly results. BHF's capital generation remains problematic, constraining potential returns. Management is addressing issues, but uncertainty persists, impacting profitability and growth. The company is considering reinsurance to improve its capital ratio, trading off short-term profitability for capital strength. Despite buybacks reducing share count by 7.6%, BHF's capital return capacity is less attractive compared to peers like Jackson and Equitable. I maintain a "hold" rating. Read the full article on Seeking AlphaSeeking Alpha • Aug 08
Brighthouse: Weak Capital Limits Upside (Rating Downgrade)
Summary Brighthouse Financial stock has underperformed compared to competitors like Jackson Financial and Equitable, losing 19% in the past year after a series of weak results. Brighthouse reported disappointing Q2 results, with a significant loss on a statutory basis, leaving it with too little capital. The company's cash flow will be constrained due to lower capital, impacting its ability to sell new products and return capital to shareholders. With better alternatives elsewhere, investors should avoid BHF, even as strong holdco liquidity may limit downside. Read the full article on Seeking AlphaSeeking Alpha • May 10
Brighthouse: A Weak Q1, But Headwinds Are Reflected In Valuation
Summary Brighthouse Financial shares plunged 10% after disappointing quarterly results, leaving them only marginally up from a year ago. The company reported a profit from an adjusted loss by excluding actuarial adjustments, but investors are concerned about the reinsurance rate increase. Despite strong sales momentum, capital consumption from SHIELD growth is a challenge for the company. Even with lessened free cash flow, shares are relatively cheap and buybacks will continue to be meaningful. Read the full article on Seeking AlphaSeeking Alpha • Jan 15
Brighthouse: Positioned For 2024 Capital Improvement
Summary Brighthouse Financial shares have underperformed this past year due to capital performance and business complexity. The company reported adjusted earnings of $4.18 per share in Q3, up 3% from last year. Concerns about capital performance have weighed on the share price, but improvements are expected in 2024 given a reinsurance transaction and market movements. Read the full article on Seeking AlphaAnalyseartikel • May 10
Earnings Miss: Brighthouse Financial, Inc. Missed EPS And Analysts Are Revising Their Forecasts
As you might know, Brighthouse Financial, Inc. ( NASDAQ:BHF ) recently reported its first-quarter numbers. Things were...Opbrengsten en kosten
Opbrengsten en kosten
Hoe Brighthouse Financial geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 26 | 6,090 | -167 | 42 | 0 |
| 31 Dec 25 | 6,948 | 331 | 42 | 0 |
| 30 Sep 25 | 7,830 | 865 | 23 | 0 |
| 30 Jun 25 | 8,032 | 562 | 23 | 0 |
| 31 Mar 25 | 8,612 | 511 | 23 | 0 |
| 31 Dec 24 | 6,295 | 286 | 23 | 0 |
| 30 Sep 24 | 5,264 | -1,302 | 29 | 0 |
| 30 Jun 24 | 4,422 | -999 | 29 | 0 |
| 31 Mar 24 | 3,246 | -1,208 | 29 | 0 |
| 31 Dec 23 | 4,474 | -1,214 | 29 | 0 |
| 30 Sep 23 | 2,534 | -162 | 22 | 0 |
| 30 Jun 23 | 2,485 | -227 | 22 | 0 |
| 31 Mar 23 | 6,084 | 1,692 | 22 | 0 |
| 31 Dec 22 | 10,739 | 3,775 | 22 | 0 |
| 30 Sep 22 | 9,008 | 3,707 | 23 | 0 |
| 30 Jun 22 | 10,399 | 3,680 | 23 | 0 |
| 31 Mar 22 | 8,212 | 1,971 | 23 | 0 |
| 31 Dec 21 | 4,935 | 1,554 | 23 | 0 |
| 30 Sep 21 | 5,251 | -1,284 | 21 | 0 |
| 30 Jun 21 | 3,049 | -4,657 | 21 | 0 |
| 31 Mar 21 | 451 | -6,665 | 21 | 0 |
| 31 Dec 20 | 8,498 | -1,105 | 21 | 0 |
| 30 Sep 20 | 8,671 | -1,137 | 21 | 0 |
| 30 Jun 20 | 11,549 | 2,551 | 21 | 0 |
| 31 Mar 20 | 14,834 | 4,926 | 21 | 0 |
| 31 Dec 19 | 6,520 | -761 | 21 | 0 |
| 30 Sep 19 | 10,176 | 1,758 | 40 | 0 |
| 30 Jun 19 | 8,397 | 811 | 40 | 0 |
| 31 Mar 19 | 7,724 | 195 | 40 | 0 |
| 31 Dec 18 | 8,864 | 865 | 40 | 0 |
| 30 Sep 18 | 6,785 | 91 | -10 | 0 |
| 30 Jun 18 | 7,350 | -581 | 0 | 0 |
| 31 Mar 18 | 7,684 | -96 | 0 | 0 |
| 31 Dec 17 | 6,839 | -378 | 0 | 0 |
| 30 Sep 17 | 4,385 | -2,811 | 18 | 0 |
| 30 Jun 17 | 4,178 | -2,026 | 47 | 0 |
| 31 Mar 17 | 1,557 | -3,695 | 47 | 0 |
| 31 Dec 16 | 2,982 | -2,939 | 0 | 0 |
| 30 Sep 16 | 5,672 | -1,083 | 47 | 0 |
| 30 Jun 16 | 6,203 | -602 | 8 | 0 |
| 31 Mar 16 | 9,039 | 1,174 | 8 | 0 |
| 31 Dec 15 | 8,889 | 1,119 | 56 | 0 |
Kwaliteitswinsten: BHF is momenteel verliesgevend.
Groeiende winstmarge: BHF is momenteel verliesgevend.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: BHF is verlieslatend, maar heeft de verliezen de afgelopen 5 jaar met een snelheid van 15.8% per jaar verminderd.
Versnelling van de groei: Het is niet mogelijk om de winstgroei van BHF over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.
Winst versus industrie: BHF is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Insurance industrie ( 36.2% ).
Rendement op eigen vermogen
Hoge ROE: BHF heeft een negatief Return on Equity ( -1.07% ), omdat het momenteel verliesgevend is.
Rendement op activa
Rendement op geïnvesteerd vermogen
Ontdek sterk presterende bedrijven uit het verleden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/20 20:37 |
| Aandelenkoers aan het einde van de dag | 2026/05/20 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Brighthouse Financial, Inc. wordt gevolgd door 19 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Tracy Dolin-Benguigui | Barclays |
| Tracy Dolin-Benguigui | Barclays |